Studies by Wei et al. demonstrated the role of KIF2C in the positive regulation of mTORC1 signaling in hepatocellular carcinoma, indicating that an mTOR inhibitor could be a potential therapeutic intervention in hepatocellular carcinoma62. The gene discussed is KIF2C; the disease is hepatocellular carcinoma.